96 related articles for article (PubMed ID: 31827370)
1. Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study.
Narayanan P; Dattatreya PS; Prasanna R; Subramanian S; Jain K; Somanath NS; Joshi N; Bunger D; Khan MA; Chaturvedi A; Ahmad I
Sarcoma; 2019; 2019():3158590. PubMed ID: 31827370
[TBL] [Abstract][Full Text] [Related]
2. Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study.
Subramanian S; Prasanna R; Biswas G; Das Majumdar SK; Joshi N; Bunger D; Khan MA; Ahmad I
Breast Cancer (Dove Med Press); 2020; 12():77-85. PubMed ID: 32547188
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of nanosomal docetaxel lipid suspension based chemotherapy in gastric and gastroesophageal junction adenocarcinoma.
Subramanian S; Majumdar SKD; Biswas G; Joshi N; Bunger D; Khan MA; Ahmad I
Mol Clin Oncol; 2020 Sep; 13(3):14. PubMed ID: 32754328
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of nanosomal docetaxel lipid suspension-based chemotherapy in squamous cell carcinoma of the head and neck: A multicenter retrospective study.
Kumar Das Majumdar S; Subramanian S; Biswas G; Joshi N; Khan MA; Ahmad I
Oncol Lett; 2020 Dec; 20(6):344. PubMed ID: 33123255
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer.
Badiginchala R; Dattatreya PS; Suresh AVS; Nirni SS; Andra VV; Bunger D; Chaturvedi A
Onco Targets Ther; 2023; 16():215-225. PubMed ID: 37033671
[TBL] [Abstract][Full Text] [Related]
6. A Multicentric, Retrospective Efficacy and Safety Study of Nanosomal Docetaxel Lipid Suspension in Metastatic Castration-Resistant Prostate Cancer.
Samar A; Tiwari S; Subramanian S; Joshi N; Sejpal J; Khan MA; Ahmad I
Prostate Cancer; 2020; 2020():4242989. PubMed ID: 33381320
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of nanosomal docetaxel lipid suspension based chemotherapy in metastatic ovarian carcinoma: A retrospective study.
Subramanian S; Samar A; Joshi N; Sejpal J; Khan MA; Ahmad I
Mol Clin Oncol; 2021 Aug; 15(2):162. PubMed ID: 34194740
[TBL] [Abstract][Full Text] [Related]
8. Biweekly DoceAqualip in mCRPC patients beyond 20 cycles: A case series.
Tiwari S; Bisaria A; Kaur H; Joshi N; Sejpal J; Khan MA
J Oncol Pharm Pract; 2021 Dec; 27(8):2030-2034. PubMed ID: 33853469
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of a novel nanosomal docetaxel lipid suspension compared with taxotere in locally advanced or metastatic breast cancer patients.
Ahmad A; Sheikh S; Taran R; Srivastav SP; Prasad K; Rajappa SJ; Kumar V; Gopichand M; Paithankar M; Sharma M; Rane RC; Ahmad I
Clin Breast Cancer; 2014 Jun; 14(3):177-81. PubMed ID: 24287370
[TBL] [Abstract][Full Text] [Related]
10. Nanosomal docetaxel lipid suspension based chemotherapy in a pregnant MBC patient - a case report.
Ramaswamy R; Joshi N; Khan MA; Siddhara S
Onco Targets Ther; 2019; 12():5679-5685. PubMed ID: 31406465
[TBL] [Abstract][Full Text] [Related]
11. Nanosomal Docetaxel Lipid Suspension: A Guide to Its Use in Cancer.
McKeage K
Clin Drug Investig; 2017 Apr; 37(4):405-410. PubMed ID: 28255844
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma.
Wang HY; Chu JF; Zhang P; Wang JQ; Yan Z; Yao SN; Yao ZH; Liu YY
Onco Targets Ther; 2020; 13():1561-1568. PubMed ID: 32110053
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.
De Sanctis R; Marrari A; Marchetti S; Mussi C; Balzarini L; Lutman FR; Daolio P; Bastoni S; Bertuzzi AF; Quagliuolo V; Santoro A
Drug Des Devel Ther; 2015; 9():5785-91. PubMed ID: 26604682
[TBL] [Abstract][Full Text] [Related]
14. Successful downstaging of locally recurrent penile squamous cell carcinoma with neoadjuvant nanosomal docetaxel lipid suspension (NDLS) based regimen followed by curative surgery.
Gupta S; Pawar SS; Bunger D
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29133580
[TBL] [Abstract][Full Text] [Related]
15. Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Du C; Ying H; Zhou J; Hu C; Zhang Y
Int J Clin Oncol; 2013 Jun; 18(3):464-71. PubMed ID: 22527846
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
Kong L; Zhang YW; Hu CS; Guo Y
Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
Hurvitz SA; Martin M; Symmans WF; Jung KH; Huang CS; Thompson AM; Harbeck N; Valero V; Stroyakovskiy D; Wildiers H; Campone M; Boileau JF; Beckmann MW; Afenjar K; Fresco R; Helms HJ; Xu J; Lin YG; Sparano J; Slamon D
Lancet Oncol; 2018 Jan; 19(1):115-126. PubMed ID: 29175149
[TBL] [Abstract][Full Text] [Related]
18. Clinical study of apatinib in the treatment of stage IV osteogenic sarcoma after failure of chemotherapy.
Liao Z; Li T; Zhang C; Liu X; Xing R; Teng S; Yang Y; Zhao G; Bai X; Zhao J; Yang J
Cancer Biol Med; 2020 May; 17(2):501-512. PubMed ID: 32587785
[No Abstract] [Full Text] [Related]
19. Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial.
Tomasello G; Liguigli W; Poli R; Lazzarelli S; Brighenti M; Negri F; Curti A; Martinotti M; Olivetti L; Rovatti M; Donati G; Passalacqua R
Gastric Cancer; 2014 Oct; 17(4):711-7. PubMed ID: 24282019
[TBL] [Abstract][Full Text] [Related]
20. Phase II Study of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy for Operable Breast Cancer Patients (N-1 Study).
Nakagawa M; Ikeuchi M; Morimoto M; Takechi H; Toba H; Yoshida T; Okumura K; Hino N; Nishisho A; Tangoku A
Clin Breast Cancer; 2019 Feb; 19(1):10-16. PubMed ID: 30340871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]